White women overrepresented in gynecologic cancer trials
White women are disproportionately represented in clinical trials for gynecologic cancers, according to a study published online Dec. 7 in JAMA Network Open.
Dec 12, 2023
0
0
White women are disproportionately represented in clinical trials for gynecologic cancers, according to a study published online Dec. 7 in JAMA Network Open.
Dec 12, 2023
0
0
Early diagnosis of high-grade serous ovarian cancer (HGSOC) seems feasible through analysis of genomic alterations in DNA from Papanicolaou (Pap) test smears, according to a study published online Dec. 6 in Science Translational ...
Dec 11, 2023
0
0
Using fertility preservation and/or assisted reproductive technologies (ART) did not adversely impact three-year cancer recurrence rates among patients with hormone receptor (HR)-positive breast cancer who paused endocrine ...
Dec 7, 2023
0
0
Ovarian cancer is the deadliest cancer of the female reproductive system, and there is no screening test that can help with early detection. Ultrasound imaging, the standard of care used to determine whether lesions are cancerous ...
Dec 7, 2023
0
0
To identify potential therapeutic targets and preclinical drug candidates for the treatment of ovarian cancer, researchers led by Tan Li from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences ...
Nov 24, 2023
0
146
The most effective step to battling ovarian cancer may have little to do with ovaries and more to do with surgical removal of the fallopian tubes.
Nov 20, 2023
0
0
A New York City woman who died Sunday from cancer has raised enough money to erase millions of dollars in medical debt with a posthumous plea for help.
Nov 18, 2023
0
0
Our DNA is not indestructible. Throughout the course of our lives, DNA can break in response to natural and environmental factors. Thankfully, our bodies have dedicated enzymes and pathways which can glue our broken DNA back ...
Nov 15, 2023
0
20
A model based on artificial intelligence is able to predict the therapy outcome (measured by volumetric reduction of tumor lesions) in 80% of ovarian cancer patients. The AI-based model has an accuracy of 80%, significantly ...
Nov 13, 2023
0
17
Question: I'm a 28-year-old woman recently diagnosed with breast cancer. My care team recommends starting treatment as soon as possible. While I'm ready to do the necessary treatments, I'm worried about the affect it may ...
Nov 10, 2023
0
0